Literature DB >> 28232288

Nano-ophthalmology: Applications and considerations.

Mohammad Amin Kamaleddin1.   

Abstract

The advent of nanotechnology promises to drastically accelerate progress toward nanomedicine. Nanoscale particles in the size range of cellular and molecular structures, which are usually referred to as nanoparticles (NPs), can be designed to improve penetration, sustained delivery, and controlled release of different drugs for ophthalmic therapeutic applications. After explaining different forms of routinely-used NPs such as nanomicelles, nanosuspensions, liposomes, and dendrimers, potential applications of NPs for the treatment of anterior and posterior eye diseases will be discussed by highlighting their ubiquitous properties. Furthermore, genotoxicity, cytotoxicity, and neuronal toxicity, as the major limiting factors in the wider application of NPs in medical sciences have been discussed, and novel diagnostic techniques and nanomedical tools being utilized in ophthalmology have been introduced. The development of an effective, nontoxic nanoscale biomaterials, in combination with identifying the best delivery systems, will shed more light on the future applications of nanotechnology in ophthalmology.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug delivery; Nanomedicine; Nanoparticle; Ocular disease; Toxicity

Mesh:

Substances:

Year:  2017        PMID: 28232288     DOI: 10.1016/j.nano.2017.02.007

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  17 in total

Review 1.  Challenges and opportunities for drug delivery to the posterior of the eye.

Authors:  Fernando J Cabrera; Daniel C Wang; Kartik Reddy; Ghanashyam Acharya; Crystal S Shin
Journal:  Drug Discov Today       Date:  2019-06-05       Impact factor: 7.851

Review 2.  Recent advances in intraocular sustained-release drug delivery devices.

Authors:  Yiqi Cao; Karen E Samy; Daniel A Bernards; Tejal A Desai
Journal:  Drug Discov Today       Date:  2019-06-04       Impact factor: 7.851

Review 3.  Therapeutic implications of nanomedicine for ocular drug delivery.

Authors:  Tuo Meng; Vineet Kulkarni; Russell Simmers; Vikram Brar; Qingguo Xu
Journal:  Drug Discov Today       Date:  2019-05-15       Impact factor: 7.851

4.  Ocular Inserts of Voriconazole-Loaded Proniosomal Gels: Formulation, Evaluation and Microbiological Studies.

Authors:  Ghada Ahmed El-Emam; Germeen N S Girgis; Mohamed M Adel El-Sokkary; Osama Abd El-Azeem Soliman; Abd El Gawad H Abd El Gawad
Journal:  Int J Nanomedicine       Date:  2020-10-12

Review 5.  Metallic Engineered Nanomaterials and Ocular Toxicity: A Current Perspective.

Authors:  Krista M Cosert; Soohyun Kim; Iman Jalilian; Maggie Chang; Brooke L Gates; Kent E Pinkerton; Laura S Van Winkle; Vijay Krishna Raghunathan; Brian C Leonard; Sara M Thomasy
Journal:  Pharmaceutics       Date:  2022-05-03       Impact factor: 6.525

Review 6.  The Evolving Treatment of Diabetic Retinopathy.

Authors:  Sam E Mansour; David J Browning; Keye Wong; Harry W Flynn; Abdhish R Bhavsar
Journal:  Clin Ophthalmol       Date:  2020-03-04

Review 7.  Polysaccharides in Ocular Drug Delivery.

Authors:  Natallia Dubashynskaya; Daria Poshina; Sergei Raik; Arto Urtti; Yury A Skorik
Journal:  Pharmaceutics       Date:  2019-12-24       Impact factor: 6.321

Review 8.  Nanomedicine: Insights from a Bibliometrics-Based Analysis of Emerging Publishing and Research Trends.

Authors:  Nicola Luigi Bragazzi
Journal:  Medicina (Kaunas)       Date:  2019-12-15       Impact factor: 2.430

Review 9.  Emerging Nano-Formulations and Nanomedicines Applications for Ocular Drug Delivery.

Authors:  Dawin Khiev; Zeinab A Mohamed; Riddhi Vichare; Ryan Paulson; Sofia Bhatia; Subhra Mohapatra; Glenn P Lobo; Mallika Valapala; Nagaraj Kerur; Christopher L Passaglia; Shyam S Mohapatra; Manas R Biswal
Journal:  Nanomaterials (Basel)       Date:  2021-01-12       Impact factor: 5.076

Review 10.  The utility and risks of therapeutic nanotechnology in the retina.

Authors:  Melanie Scheive; Saeed Yazdani; Amir R Hajrasouliha
Journal:  Ther Adv Ophthalmol       Date:  2021-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.